Lynora Saxinger Selected Research

Lynora Saxinger Research Topics

7	Infections 02/2023 - 04/2013
4	COVID-19 01/2023 - 01/2021
1	Rheumatic Diseases (Rheumatism) 01/2023
1	Vasculitis (Vasculitides) 01/2023
1	HIV Infections (HIV Infection) 01/2022
1	Clostridium Infections 11/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2019
1	Fibrosis (Cirrhosis) 12/2017
1	Hemorrhage 12/2017
1	Bacterial Infections (Bacterial Infection) 12/2017
1	Cross Infection (Nosocomial Infection) 03/2015
1	Felty Syndrome (Syndrome, Felty's) 04/2013
1	Pneumonia (Pneumonitis) 04/2013

2	COVID-19 VaccinesIBA 01/2023 - 01/2023
2	VaccinesIBA 01/2023 - 01/2023
1	FidaxomicinIBA 02/2023
1	AntigensIBA 01/2023
1	casirivimab and imdevimab drug combinationIBA 01/2022
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 01/2022
1	remdesivirIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Lopinavir FDA Link 01/2019
1	Emtricitabine (Emtriva)FDA Link 01/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	Reverse Transcriptase InhibitorsIBA 01/2019
1	Ritonavir (Norvir)FDA Link 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2017
1	Anti-Infective Agents (Microbicides)IBA 03/2015
1	CoagulaseIBA 04/2013
1	Vancomycin FDA LinkGeneric 04/2013

1	Length of Stay 04/2022
1	Fecal Microbiota Transplantation 11/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Personal Protective Equipment 10/2020
1	Highly Active Antiretroviral Therapy (HAART) 01/2019
1	Antibiotic Prophylaxis 12/2017
1	Therapeutics 12/2017